Laboratory Characteristics in Chronic Atrophic Acrodermatitis

NCT02147262 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Chronic Atrophic Acrodermatitis

Interventions

DRUG: doxycycline orally, 100 mg, bid, 14 days
DRUG: doxycycline orally, 100 mg, bid, 28 days

Sponsor

University Medical Centre Ljubljana

Collaborators

[object Object]
[object Object]
[object Object]